Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted chromans and their use in the treatment of asthma, arthritis and related diseases

Substituted chromans and their use in the treatment of asthma, arthritis and related diseases

US Patent 5298512 · Granted Mar 29, 1994

Estimated economic value: $28,033,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isotopically-labelled trapidil derivatives2025
Crystalline forms and methods of producing crystalline forms of a compound2025
Rapamycin for the treatment of lymphangioleiomyomatosis2024
Compositions for the treatment of fibrosis and inflammation2024
Oxabicycloheptane prodrugs2024
Crystalline forms and methods of producing crystalline forms of a compound2023
Rapamycin for the treatment of lymphangioleiomyomatosis2023
Compositions for the treatment of fibrosis2023
Inhalable rapamycin formulation for treating age-related conditions2023
Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022
Oxabicycloheptane prodrugs2022
Rapamycin for the treatment of lymphangioleiomyomatosis2021